Grade 3 Meningioma

subtype

Identifier: CI-CAN-00002790
Entity page: /cancer/grade-3-meningioma ↗
Edges: 67

Neighbours: 26 drugs10 trials
Drawn: 36 of 36 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Grade 3 Meningioma investigated in trials for …INVESTIGATED_IN_TRIALSderived26 of 26show fewer
→ investigated in trials for	Temozolomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Grade 3 Meningioma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants

Grade 3 Meningioma studied in …STUDIED_INderived10 of 41show all (up to 200)
→ studied in	NCT02847559Phase 2 · completed Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma · condition mapped CURATED_BROADER · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06557512NA · recruiting Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03604978Phase 1/Phase 2 · active not recruiting Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma · condition mapped ONTOLOGY_EXACT · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06275919Phase 2 · recruiting Regorafenib for Recurrent Meningioma (MIRAGE Trial) · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07552233NA · recruiting NK Cell Therapy for Malignant Solid Brain Tumors · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04082520Phase 2 · recruiting Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy · condition mapped ONTOLOGY_EXACT · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04659811Phase 2 · active not recruiting Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Adult Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04278118NA · recruiting Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study · condition mapped CURATED_BROADER · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Anaplastic (Malignant) Meningioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07172178early Phase 1 · not yet recruiting γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma · condition mapped ALIAS · 41 trials mapped (10 active)	—	—	Grade 3 Meningioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains